Peter Francis

Chief Medical Officer & Chief Scientific Officer • Ray Therapeutics

Peter Francis is a highly experienced biotechnology executive and an ophthalmologist clinician-scientist with expertise in ophthalmic genetics and retinal disease. He graduated from medical school in the U.K. and undertook residency in London. He obtained his PhD in ophthalmic genetics from University College, London and is fellowship trained in Retina.

Peter has almost two decades of experience in the biotechnology and pharmaceutical industries where he has led a number of gene therapy products from discovery to early-stage clinical development. Most recently he served as Chief Scientific Officer at 4D Molecular Therapeutics, a leader in AAV-based gene therapy and was prior, their first Chief Medical Officer and Head of Translational Research. Previously, Peter was Chief Medical Officer at RetroSense Therapeutics, the first visual optogenetics company which was successfully sold to a large pharmaceutical company.

Peter is a member of the Macula Society, the American Ophthalmological Society and the American Academy of Ophthalmology. He has held academic faculty positions at St. Thomas’ Hospital, London and Casey Eye Institute, OHSU, Portland, OR. He has published about 100 peer-reviewed articles.

Also Speaking

Stephen Sullivan

Founder • Lindville Bio

Teonna Woolford

Chief Executive Officer • Sickle Cell Reproductive Health Education Directive

Kristin Viswanathan Wolff

Vice President, Market Access  • bluebird bio

Also Speaking


Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.


Find out more and apply to get involved at the briefings taking place at Advanced Therapies Week.